The Class of 2015 Isn’t Ready to Join the Workforce
The improving economy means that more employers are offering decent jobs to the Class of 2015, but many of those new graduates don’t feel ready to join the working world.
Only 35 percent of students believe that college was effective in preparing them for a job, and even fewer — 20 percent — feel very prepared to enter the workforce, according to the 2015 Workforce Readiness Survey by McGraw Hill Education.
More than half of students surveyed said they never learned to write a resume in college or how to conduct themselves in a job interview. Nearly 60 percent said they didn’t know how to network or search for a job.
Related: Why the Class of 2015 May Actually Get Good Jobs
The job market has loosened up this year — employers expect to hire nearly 10 percent more new college graduates this year than last year, according ot a study released last month by the National Association of Colleges and Employers. Still, the best gigs remain very competitive, and students who don’t know how to navigate the job search process may find themselves at a disadvantage.
Two-thirds of those surveyed said that they wanted to get more internships or professional experience while in school, and about 60 percent wanted more time to focus on career prep.
Colleges regularly tout their career services departments, but the students surveyed for this report gave those offices poor marks. Only a third thought that their school’s career services department was effective, and a quarter had never used career services.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
